OVID Q1 2026 Earnings Narrower Loss and No Revenue Mark a Quiet Quarter for the Biotech TME Q1 2026 Earnings EPS Beat Opaque as Stock Declines Amid Limited Disclosure Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS TBLA Q1 2026 Earnings EPS Beats Estimates by 68 as Shares Edge Lower PODC Q1 2026 Earnings EPS Beats Estimates by 5798 Stock Surges 667 FBRX Q1 2026 Earnings PreRevenue Biotech Reports Narrow EPS Miss Amid Ongoing Development